|
| | Publication Year | Title | Author(s) |
| 481 | 21-Feb-2022 | Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer. | Ermongkonchai, Tai; Khor, Richard ; Muralidharan, Vijayaragavan ; Tebbutt, Niall C ; Lim, Kelvin K M ; Kutaiba, Numan ; Ng, Sweet Ping |
| 482 | 1-Dec-2010 | Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathway. | Weickhardt, Andrew J ; Tebbutt, Niall C ; Mariadason, John M |
| 483 | 4-May-1992 | Subdural haematoma presenting with transient neurological deficits. | Cher, Lawrence M ; White, O B |
| 484 | 6-Jul-2022 | Sunvozertinib, a selective EGFR inhibitor for previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations. | Wang, Mengzhao; Yang, James Chih-Hsin; Mitchell, Paul L R ; Fang, Jian; Camidge, D Ross; Nian, Weiqi; Chiu, Chao-Hua; Zhou, Jianying; Zhao, Yanqiu; Su, Wu-Chou; Yang, Tsung-Ying; Zhu, Viola W; Millward, Michael; Fan, Yun; Huang, Wen-Tsung; Cheng, Ying; Jiang, Liyan; Brungs, Daniel; Bazhenova, Lyudmila; Lee, Chee Khoon; Gao, Bo; Xu, Yan; Hsu, Wei-Hsun; Zheng, Li; Janne, Pasi A |
| 5 | Aug-2023 | Surgical management of breast cancer in Victoria: A state-wide audit. | Sung, Nakjun; Muthusamy, Arun; Finn, Norah; Stuart, Ella; Fox, Jane; Yeo, Belinda |
| 6 | Jun-2017 | Survival and functional outcomes of patients with metastatic solid organ cancer admitted to the intensive care unit of a tertiary centre | Ha, Francis J; Weickhardt, Andrew J ; Parakh, Sagun ; Vincent, Andrew D; Glassford, Neil J; Warrillow, Stephen J ; Jones, Daryl A |
| 7 | 24-Nov-2023 | Survival outcomes of intracranial extraventricular neurocytomas: a systematic review and individual patient data meta-analysis. | Kweh, Barry Ting Sheen; Asaid, Mina; Khoo, Boyuan; Donaldson, Christopher; Lokan, Julie ; Gan, Hui K ; Gonzalvo, Augusto Carlos |
| 8 | Aug-2020 | Sustained remission of Lynch syndrome-associated metastatic adrenocortical carcinoma following checkpoint inhibitor therapy-associated multiorgan autoimmunity. | Nevgi, Aditi; Klein, Oliver ; Cheung, Ada S |
| 9 | Jan-2016 | Symptom clusters in advanced cancer patients: an empirical comparison of statistical methods and the impact on quality of life | Dong, Skye T; Costa, Daniel SJ; Butow, Phyllis N; Lovell, Melanie R; Agar, Meera; Velikova, Galina; Teckle, Paulos; Tong, Allison; Tebbutt, Niall C ; Clarke, Stephen J; van der Hoek, Kim; King, Madeleine T; Fayers, Peter M |
| 10 | 3-Mar-2022 | The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective. | Senko, Clare ; Gunjur, Ashray ; Balasubramanian, Adithya ; Gan, Hui K ; Parakh, Sagun ; Cher, Lawrence M |
| 11 | Apr-2019 | Systemic treatment of advanced hepatocellular cancer: new hope on the horizon. | Chang Lee, Rachael; Tebbutt, Niall C |
| 12 | Aug-2016 | TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. | Ferraro, D; Goldstein, D; O'Connell, R L; Zalcberg, J R; Sjoquist, K M; Tebbutt, Niall C ; Grimison, P; McLachlan, S; Lipton, L L; Vasey, P; Gebski, V J; Aiken, C; Cronk, M; Ng, S ; Karapetis, C S; Shannon, J |
| 13 | 6-Jun-2022 | Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma. | Cilento, Michael A; Klein, Oliver ; Egan, Elizabeth; Roberts-Thomson, Rachel |
| 14 | Oct-2018 | Targeted therapy for metastatic colorectal cancer. | Price, Timothy J; Tang, Monica; Gibbs, Peter; Haller, Daniel G; Peeters, Marc; Arnold, Dirk; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew; Shapiro, Jeremy |
| 15 | 11-May-2009 | Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization. | Gan, Hui K ; Lappas, Martha; Cao, Diana; Cvrljevdic, Anna; Scott, Andrew M ; Johns, Terrance G |
| 16 | 2-Oct-2020 | Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma. | Chia, Puey Ling ; Parakh, Sagun ; Tsao, Ming-Sound; Pham, Nhu-An; Gan, Hui K ; Cao, Diana; Burvenich, Ingrid J G; Rigopoulos, Angela; Reilly, Edward B; John, Thomas ; Scott, Andrew M |
| 17 | 4-May-2023 | Targeting homologous recombination deficiency in uterine leiomyosarcoma | Dall, Genevieve; Vandenberg, Cassandra J; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H A; Bedő, Justin; Penington, Jocelyn; Wakefield, Matthew J; Kee, Damien ; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P; Dobrovic, Alexander ; Fox, Stephen B; McNally, Orla; Power, Jeremy D; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M; Klein, Oliver ; Barnett, Stephen A ; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T; Scott, Clare L; Barker, Holly E |
| 18 | Oct-2020 | Targeting Multiple EGFR Expressing Tumors with a Highly Potent Tumor-Selective Antibody Drug Conjugate. | Anderson, Mark G; Falls, Hugh D; Mitten, Michael J; Oleksijew, Anatol; Vaidya, Kedar S; Boghaert, Erwin R; Gao, Wenqing; Palma, Joann P; Cao, Diana; Chia, Puey Ling ; John, Thomas ; Gan, Hui K ; Scott, Andrew M ; Reilly, Edward B |
| 19 | 1-Jun-2012 | Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy. | Gan, Hui K ; Burgess, Antony W; Clayton, Andrew H A; Scott, Andrew M |
| 20 | 1-Jul-2003 | Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies. | Mitchell, Paul L R ; Lee, Fook-Thean; Hall, Cathrine; Rigopoulos, Angela; Smyth, Fiona E; Hekman, Anne-Marie; van Schijndel, Gijs M; Powles, Ray; Brechbiel, Martin W; Scott, Andrew M |
